In the present study, preoperative VEGF levels in the NSCLC patients were significantly higher than in the controls, and declined continuously throughout the first postoperative week to reach a level similar to that of the controls, after which they plateaued for 1 month. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.